CAMBRIDGE, Mass., May 5 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals
Incorporated (Nasdaq: VRTX) will webcast its 2005 Annual Meeting of
Shareholders on Wednesday, May 11, 2005. Joshua Boger, Ph.D., Vertex's
Chairman and Chief Executive Officer, will host the webcast which will begin
at 9:30 a.m. EDT.
The live webcast may be accessed by visiting the Vertex website at
http://www.vrtx.com. A replay of the webcast will also be available on the
Company's website until May 25, 2005. To access the webcast, go to Vertex's
website and select '2005 Annual Meeting of Shareholders.' To ensure a timely
connection to the webcast, it is recommended that users register at least 15
minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. In collaboration with
GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor, Lexiva(R).
Lexiva(R) is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
Company News On-Call:
http://www.prnewswire.com/comp/938395.html
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
